Home/Filings/4/0001415889-24-010569
4//SEC Filing

Terrillion Scott 4

Accession 0001415889-24-010569

CIK 0001346830other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:21 PM ET

Size

5.1 KB

Accession

0001415889-24-010569

Insider Transaction Report

Form 4
Period: 2024-04-05
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
  • Sale

    Common Stock

    2024-04-05$0.83/sh2,753$2,28588,247 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001706426

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:21 PM ET
Size
5.1 KB